Morgan Stanley’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-381,412
| Closed | -$52.1M | – | 6970 |
|
|
2018
Q2 | $52.1M | Buy |
381,412
+269,219
| +240% | +$24.5M | 0.01% | 886 |
|
|
2018
Q1 | $8.84M | Buy |
112,193
+62,099
| +124% | +$4.58M | ﹤0.01% | 2457 |
|
|
2017
Q4 | $3.42M | Buy |
50,094
+20,082
| +67% | +$1.04M | ﹤0.01% | 3506 |
|
|
2017
Q3 | $1.21M | Sell |
30,012
-10,938
| -27% | -$422K | ﹤0.01% | 4313 |
|
|
2017
Q2 | $1.63M | Buy |
40,950
+10,313
| +34% | +$378K | ﹤0.01% | 3978 |
|
|
2017
Q1 | $988K | Sell |
30,637
-19,315
| -39% | -$482K | ﹤0.01% | 4388 |
|
|
2016
Q4 | $883K | Buy |
49,952
+34,457
| +222% | +$742K | ﹤0.01% | 4558 |
|
|
2016
Q3 | $362K | Sell |
15,495
-9,290
| -37% | -$211K | ﹤0.01% | 4715 |
|
|
2016
Q2 | $463K | Buy |
24,785
+1,454
| +6% | +$26.3K | ﹤0.01% | 4470 |
|
|
2016
Q1 | $425K | Sell |
23,331
-14,628
| -39% | -$236K | ﹤0.01% | 4545 |
|
|
2015
Q4 | $800K | Buy |
37,959
+25,206
| +198% | +$486K | ﹤0.01% | 4210 |
|
|
2015
Q3 | $235K | Sell |
12,753
-5,282
| -29% | -$132K | ﹤0.01% | 5006 |
|
|
2015
Q2 | $611K | Buy |
18,035
+1,403
| +8% | +$56.4K | ﹤0.01% | 4568 |
|
|
2015
Q1 | $800K | Sell |
16,632
-6,541
| -28% | -$297K | ﹤0.01% | 4303 |
|
|
2014
Q4 | $515K | Buy |
23,173
+2,609
| +13% | +$60.2K | ﹤0.01% | 4635 |
|
|
2014
Q3 | $389K | Sell |
20,564
-441
| -2% | -$10.5K | ﹤0.01% | 4740 |
|
|
2014
Q2 | $567K | Sell |
21,005
-40,980
| -66% | -$1.04M | ﹤0.01% | 4487 |
|
|
2014
Q1 | $2.01M | Sell |
61,985
-112,254
| -64% | -$3.65M | ﹤0.01% | 3417 |
|
|
2013
Q4 | $4.15M | Buy |
+174,239
| New | +$4.87M | ﹤0.01% | 2744 |
|
Morgan Stanley's FMI Position: Q3 2018 in Review
Morgan Stanley sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 381,412 shares — an estimated $52.1M sold.
Morgan Stanley first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $52.1M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Morgan Stanley reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Morgan Stanley sold 381,412 Foundation Medicine, Inc. shares in Q3 2018, an estimated $52.1M.
- Morgan Stanley first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Morgan Stanley's Foundation Medicine, Inc. position peaked at $52.1M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.